Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis - Wikidata - wikimedia - TriplyDB

Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis

Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis

http://www.wikidata.org/entity/Q28263151

about

Controversies in the management of primary sclerosing cholangitis Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy How Should Cancer Surveillance in Primary Sclerosing Cholangitis Be Performed?Current diagnostic and management options in perihilar cholangiocarcinoma Current endoscopic approach to indeterminate biliary strictures Primary sclerosing cholangitis: diagnosis and treatment Novel endoscopic approaches in the diagnosis and management of biliary strictures Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management Classification, diagnosis, and management of cholangiocarcinoma Update on the Diagnosis and Treatment of Cholangiocarcinoma.Endoscopic management of hilar cholangiocarcinoma.Pathogenesis and clinical spectrum of primary sclerosing cholangitis.Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.ERCP with probe-based confocal laser endomicroscopy for the evaluation of dominant biliary stenoses in primary sclerosing cholangitis patients.Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis Cancer surveillance in patients with primary sclerosing cholangitis.Probe-Based Confocal Endomicroscopy in Primary Sclerosing Cholangitis: Not All Inflammatory Strictures Are the Same.The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma.Systematic review with meta-analysis: endoscopic retrograde cholangiopancreatography-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.Immunoglobulin g4-associated cholangitis: the next great masquerader.Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications Endoscopic retrograde cholangiopancreatography for non-gastroenterologists: what you need to know.Beyond cytomorphology: expanding the diagnostic potential for biliary cytology.Improving the accuracy of pancreatobiliary tract cytology with fluorescence in situ hybridization: a molecular test with proven clinical success.Primary Sclerosing Cholangitis: Current and Future Management Strategies.Novel diagnostic and prognostic biomarkers in biliary tract cancer.Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis.FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytology.Screening for malignancy in primary sclerosing cholangitis (PSC).Primary sclerosing cholangitis - the Norwegian experience.Diagnostic utility of single-user peroral cholangioscopy in sclerosing cholangitis.Diagnosis and management of primary sclerosing cholangitis-perspectives from a therapeutic endoscopist.Hilar cholangiocarcinoma: expert consensus statement.Are Dominant Strictures in Primary Sclerosing Cholangitis a Risk Factor for Cholangiocarcinoma?ETS Proto-oncogene 1 Transcriptionally Up-regulates the Cholangiocyte Senescence-associated Protein Cyclin-dependent Kinase Inhibitor 2A.Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway.

P2860

Q26765804-FF50AC75-1761-420B-BB59-E1E1EDE45107 Q26767120-653F1297-AD68-45B8-9D00-1F95FE0367D9 Q26782878-0C2DB544-E240-480E-90F0-916F16A684BD Q26822808-9AFC4F75-EDE9-4BE5-8289-2D331D206D45 Q26824862-9272B87D-7A2E-4372-A0D5-075628F61100 Q26829216-D94A5BFA-FC13-4048-848B-7441545C4D4E Q26853187-C147046F-24AB-41F9-B2CC-70DB07F3C427 Q27015831-41B035AE-4246-4758-A56C-A07C226E8072 Q28275153-31193B15-BD94-439A-B8C4-A60823410AE5 Q30238895-662E333C-33D0-4E86-9182-0C4A666FAF74 Q31046234-5E4AD571-47A1-415A-8749-6B8262B492A7 Q33572623-CE1ECA50-A963-4C86-A0D6-BFC94ADF6942 Q34479345-7754F115-9BE5-48B8-9B7F-B2255C0F73F1 Q34615653-77D39678-EABC-47D7-BEE9-DD094F631C16 Q35146460-DEA0B70E-A5A9-4A63-9DA6-FF7D7928E4FD Q35490961-254FA512-D7CE-4C66-AA1E-A9E504B160F7 Q35733256-FD7217AC-4AB1-415D-9ED6-8C0BA701089F Q35956062-2FD489EC-FB0F-4B39-B7A6-C55AC712C271 Q36151669-DD4CF86E-6161-4BAB-AA51-CA3F3454A1B1 Q36199767-63268E82-92F8-41C1-80AA-2A2A5E360AFC Q36644248-9BA9A37E-13E5-4D1F-8316-6991FF236AA9 Q36683019-AC71851F-BCF6-4F75-ADE9-4AB565B9BBC4 Q37688351-8937AC3B-F239-450C-86CF-7D255B92E33E Q37706763-8E7586CD-5C5A-41D4-AED1-9BAB1BCFC691 Q37876078-3DC6E80E-4134-4F8E-AC40-1E5973A29A26 Q38012419-E57A63AE-D7F6-464C-B3DB-2308F47879DA Q38103214-48A84077-E317-497C-A990-6C6F7E1AC44A Q38107484-4C15CA3F-0D9A-46CF-B935-E2D57BE21326 Q38131056-4845F108-11F0-48A2-A6A5-F528B4ADA288 Q38174167-EEBDF7E4-9E79-4661-9ED1-E4FF73D28E80 Q38235122-1E865F15-A5FC-463A-A6EA-4C5CE3DB4C3C Q38383074-2BE68246-F618-4CC7-8ACA-C59C65E84C65 Q38417642-F0D9637B-A4DE-488D-BA4F-E25854B6C868 Q38419868-528CB99D-DCE3-49A7-912C-B2CFE9670787 Q38443665-E9D00CBC-0C4A-4ED5-8EDE-1B67825CB2BE Q38546730-0E2ABFBA-13DD-47D4-BB56-F5BA4BA8249F Q38657903-79607C0D-D4EA-49AF-9216-0BC2D7664681 Q38717030-D7E00D90-F8B3-4086-8898-1D2CC6E2A6BD Q41624551-09DD5DB9-DC7F-4C5D-AD21-635C9447021B Q42151602-4139EFCF-8D0A-4C91-BA6C-CA4D35F056D7

P2860

Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis

http://www.wikidata.org/entity/Q28263151

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Long-term outcomes of positive ...... primary sclerosing cholangitis

@ast

Long-term outcomes of positive ...... primary sclerosing cholangitis

@en

Long-term outcomes of positive ...... primary sclerosing cholangitis

@nl

type

label

Long-term outcomes of positive ...... primary sclerosing cholangitis

@ast

Long-term outcomes of positive ...... primary sclerosing cholangitis

@en

Long-term outcomes of positive ...... primary sclerosing cholangitis

@nl

prefLabel

Long-term outcomes of positive ...... primary sclerosing cholangitis

@ast

Long-term outcomes of positive ...... primary sclerosing cholangitis

@en

Long-term outcomes of positive ...... primary sclerosing cholangitis

@nl

P1433

Q28263151-36513178-700E-4ABE-B581-1A6CB875D5FF

P1476

Q28263151-5E8D9953-96CF-4FD7-855D-8692FE8FA40D

P2093

Q28263151-22E36682-174B-43B4-99B0-9184595A8A35

Q28263151-3D6C2E53-5BBB-4139-81EA-BE522759EDDF

Q28263151-4DFC0699-2E95-4873-A7C0-400D402A0155

Q28263151-9D251070-F587-4A94-8A13-2BF61C134981

Q28263151-FEA08158-C95A-423C-81F2-BE8D0295C5A5

P2860

Q28263151-04C617EF-E690-4652-8F43-E68204A3A31B

Q28263151-0F30F52B-EBBD-4978-B7A9-68A63610589F

Q28263151-17322173-4C92-4D4C-B3B9-C52226A2C300

Q28263151-218FEEE8-A48D-4393-8C7E-0C713DB84A97

Q28263151-2627A994-3E64-4B26-8EC7-F7C24DF38A77

Q28263151-4C8FD5DC-145D-4B79-82AE-14AB9A093434

Q28263151-5196965A-ED09-4771-8167-0930E299C1DE

Q28263151-544A731C-9F37-46F0-BD1C-76EE23A2B381

Q28263151-5F9EA373-0B8E-4926-9D5C-FBCAF0551890

Q28263151-7AE1DDFB-E1F2-405E-83DA-994086A1905D

P304

Q28263151-E5EFFB7D-CDE7-4BD3-BA60-1B68EE32680C

P31

Q28263151-E5857B52-463E-479B-9CF6-74E8168EC3BA

P356

Q28263151-F2EE1F30-F99D-49E8-8F89-55684407EEB9

P407

Q28263151-0981A8A0-D5F5-4120-A9F2-1ACF57C400E9

P433

Q28263151-C0A47804-FDB9-428B-A88C-9E45E8734074

P478

Q28263151-ACDBBD8F-6DEA-4502-BDE6-0707966A35B3

P50

Q28263151-4ACB829C-7441-4033-A53B-D7FE9C63BAAF

Q28263151-CFBD286C-2C93-4D30-A1E0-DC20C5BB0BCB

P577

Q28263151-DD82881D-4D82-46B5-9528-DE71870D772B

P5875

Q28263151-21382622-2AFE-4981-AFED-AF6D94E9F72B

P698

Q28263151-E86A1277-73BB-4C44-AAD1-1511F88679D4

P921

Q28263151-76AABE45-CE6A-4263-BA7A-6DA6E00B7CF0

P356

P1433

P1476

Long-term outcomes of positive ...... primary sclerosing cholangitis

@en

P2093

Einar Bjornsson

http://www.w3.org/2001/XMLSchema#string

Emily G Barr Fritcher

http://www.w3.org/2001/XMLSchema#string

Keith D Lindor

http://www.w3.org/2001/XMLSchema#string

Kevin C Halling

http://www.w3.org/2001/XMLSchema#string

Sanjay Y Bangarulingam

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.

Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.

Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures.

Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures.

The development of a fluorescence in situ hybridization assay for the detection of dysplasia and adenocarcinoma in Barrett's esophagus.

Primary sclerosing cholangitis: summary of a workshop.

Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.

A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures.

P304

174-180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.23277

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Felicity T. Enders

Gregory J Gores

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38055602

http://www.w3.org/2001/XMLSchema#string

P698

19877179

http://www.w3.org/2001/XMLSchema#string

P921